Ethics Committee Requirements for Clinical Trials in Venezuela: A Sponsor's Guide
Everything international sponsors need to know about ethics committee review, informed consent requirements, and GCP compliance for clinical trials in Venezuela.
May 22, 2026
12
min read
By
bioaccess® Editorial Team
ethics committee Venezuela
clinical trial ethics review
bioethics clinical trials
GCP compliance Venezuela
PAHO standards
**Key Takeaways**
- • Institutional ethics committees review all clinical trials in Venezuela before INHRR submission
- • Review timeline: 4-8 weeks for ethics committee approval
- • ICF must be in Spanish and meet Venezuelan regulatory requirements
- • PAHO/WHO and CIOMS guidelines govern ethical standards
- • Venezuela follows ICH-GCP — data is accepted by FDA and EMA
Ethics oversight framework in Venezuela
Venezuela's clinical research ethics framework is built on international standards, following the Declaration of Helsinki, CIOMS International Ethical Guidelines, and PAHO/WHO recommendations. The ethics review system ensures that clinical trials conducted in Venezuela protect participant rights, safety, and well-being while generating internationally acceptable data.
For international sponsors planning first-in-human clinical trials or early feasibility studies in Venezuela, understanding the ethics committee landscape is essential for timeline planning and regulatory strategy.
Ethics committee structure and composition
Clinical trials in Venezuela are reviewed by institutional ethics committees (Comités de Ética de la Investigación) based at hospitals and clinical research centers. These committees are typically composed of:
- Physicians with clinical research experience (at least 2 members)
- A bioethics specialist or bioethics-trained member
- A legal representative or legal advisor
- A community representative (non-medical, non-scientific member)
- A pharmacist or clinical pharmacology specialist
- Additional ad hoc specialists based on the therapeutic area under review
The committee must have a minimum quorum to hold meetings, and decisions are typically made by majority vote. Most committees in Venezuela meet monthly, although some major institutions have biweekly review sessions for expedited processing.
Submission requirements for ethics review
A complete ethics committee submission in Venezuela must include:
- Clinical trial protocol (Spanish version or with certified Spanish translation)
- Investigator's Brochure or device dossier (key sections in Spanish)
- Informed Consent Form in Spanish, adapted to Venezuelan requirements
- Principal Investigator CV, medical license, and GCP certificate
- Insurance/indemnity documentation for trial participants
- Patient recruitment materials (advertisements, flyers) in Spanish
- Case Report Forms or eCRF screenshots
- Financial disclosure and conflict of interest declarations
- Sponsor authorization letter designating the local CRO as agent
Informed consent form requirements
The informed consent form (ICF) is the most critically reviewed document in the ethics submission. Venezuelan ethics committees have specific requirements:
- Must be written in clear, accessible Spanish (not technical medical jargon)
- Must explain the purpose, procedures, risks, benefits, and alternatives
- Must state that participation is voluntary and withdrawal is penalty-free
- Must describe data privacy protections and who will access patient data
- Must include contact information for the PI, ethics committee, and regulatory authority
- Must describe compensation for trial-related injuries
- Must be appropriate for the local literacy level and cultural context
**Common ICF rejection reason**
The most frequent reason for ethics committee queries on ICFs in Venezuela is overly technical language. bioaccess® recommends having ICFs reviewed by a Spanish-language health literacy specialist before submission to ensure they are comprehensible to the target patient population.
GCP compliance standards in Venezuela
Venezuela follows ICH-GCP (E6) guidelines for the conduct of clinical trials. This means:
- All investigators and study staff must have documented GCP training
- Source data must be verifiable, accurate, and complete
- Adverse events must be reported according to GCP timelines
- Monitoring visits must follow a risk-based monitoring plan
- Essential documents must be maintained in an organized Trial Master File
- All data collection instruments must be validated and version-controlled
PAHO and international ethical standards
As a member of the Pan American Health Organization (PAHO), Venezuela aligns its clinical research ethics with PAHO's guidelines for bioethics committees. Key standards include:
- CIOMS 2016 International Ethical Guidelines for Health-Related Research Involving Humans
- WHO Standards and Operational Guidance for Ethics Review of Health-Related Research
- Declaration of Helsinki (WMA, latest revision)
- Nuremberg Code principles
- Universal Declaration on Bioethics and Human Rights (UNESCO)
Review timeline and process
| Step | Activity | Timeline |
|---|---|---|
| 1 | Submit complete package to ethics committee | Day 0 |
| 2 | Administrative completeness check | 1-2 weeks |
| 3 | Scientific and ethical review by committee | 2-4 weeks |
| 4 | Committee meeting and deliberation | Meeting date |
| 5 | Queries to sponsor/CRO (if any) | 1-2 weeks |
| 6 | Response to queries | 1-2 weeks |
| 7 | Final approval letter issued | 1 week |
Venezuela vs. other LATAM countries: ethics review comparison
| Country | Ethics Review Body | Typical Timeline | Key Feature |
|---|---|---|---|
| Venezuela | Institutional ethics committee | 4-8 weeks | PAHO-aligned standards |
| Colombia | Institutional ethics committee | 4-6 weeks | INVIMA oversees ethics |
| Mexico | Ethics + COFEPRIS | 4-8 weeks | Dual review required |
| Argentina | ANMAT + provincial ethics | 6-10 weeks | ICH member, parallel review |
| Panama | CNBI ethics committee | 4-8 weeks | Ethics-driven FIH pathway |
| Brazil | CEP + CONEP | 6-12 weeks | Centralized ethics system |
How bioaccess® manages ethics submissions in Venezuela
bioaccess® provides end-to-end ethics committee management for sponsors conducting clinical trials in Venezuela. Our services include:
- Ethics committee identification and pre-submission consultation
- ICF development and Spanish-language adaptation
- Complete submission package preparation and quality review
- Ethics committee meeting scheduling and attendance
- Query management and response coordination
- Annual renewals and amendment submissions
- Ongoing ethics compliance monitoring throughout the study
**Ready to navigate ethics approval in Venezuela?**
bioaccess® has the local expertise to manage your ethics submission efficiently. Contact us to discuss your clinical trial strategy in Venezuela, or learn about our FIH CRO services.
Frequently asked questions
Get your FIH roadmap for Venezuela
bioaccess® navigates the ethics and regulatory landscape so you can focus on your science.
Get your FIH roadmap
View case studies